|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.80 INR | -0.82% |
|
+0.37% | -12.73% |
| Market Cap | 978M 10.21M 8.95M 8.27M 7.64M 14.48M 14.77M 99.38M 38.62M 478M 38.34M 37.5M 1.66B | P/E 2024 |
10.4x | P/E 2025 | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | -149M -1.56M -1.37M -1.26M -1.17M -2.21M -2.26M -15.18M -5.9M -73.06M -5.86M -5.73M -254M | EV / Sales 2024 |
0.81x | EV / Sales 2025 | 0.94x |
| Free-Float |
42.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.82% | ||
| 1 week | +0.37% | ||
| Current month | +0.37% | ||
| 1 month | -1.63% | ||
| 3 months | -2.19% | ||
| 6 months | -11.31% | ||
| Current year | -12.73% |
| 1 week | 67.1 | 70.5 | |
| 1 month | 66.61 | 73.69 | |
| Current year | 46.1 | 80.08 | |
| 1 year | 46.1 | 105.9 | |
| 3 years | 46.1 | 144.5 | |
| 5 years | 46.1 | 144.5 | |
| 10 years | 11 | 144.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paresh Chawla
CEO | Chief Executive Officer | - | 28/05/2016 |
Bakulesh C. Shah
DFI | Director of Finance/CFO | 65 | - |
Yashoda Patidar
CMP | Compliance Officer | - | 11/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | - | |
Pravin C. Shah
BRD | Director/Board Member | 77 | 01/01/1967 |
Paresh Chawla
BRD | Director/Board Member | - | 28/05/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.82% | +0.37% | -33.10% | -4.17% | 15.15M | ||
| -0.80% | +1.38% | +12.40% | +82.31% | 48.12B | ||
| -3.08% | +3.29% | +65.80% | +113.96% | 37.36B | ||
| -1.38% | -2.29% | -5.21% | +40.28% | 12.36B | ||
| -0.43% | +3.18% | +14.94% | +97.17% | 12.12B | ||
| +0.38% | +4.19% | +34.19% | +123.08% | 9.14B | ||
| -2.20% | -0.91% | +19.15% | +43.83% | 7.21B | ||
| +1.24% | +4.23% | +58.03% | -1.50% | 7.14B | ||
| -1.82% | +0.88% | +19.55% | +222.63% | 6.73B | ||
| -7.00% | +12.89% | -22.31% | +10.09% | 6.35B | ||
| Average | -1.59% | +2.33% | +16.34% | +72.77% | 14.65B | |
| Weighted average by Cap. | -1.61% | +3.19% | +27.47% | +87.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.09B 11.36M 9.96M 9.2M 8.5M 16.11M 16.43M 111M 42.95M 532M 42.65M 41.71M 1.85B | 1.12B 11.74M 10.3M 9.51M 8.79M 16.66M 16.99M 114M 44.42M 550M 44.1M 43.14M 1.91B |
| Net income | 168M 1.75M 1.54M 1.42M 1.31M 2.48M 2.53M 17.06M 6.63M 82.1M 6.58M 6.44M 285M | 195M 2.04M 1.79M 1.65M 1.52M 2.89M 2.95M 19.83M 7.7M 95.44M 7.65M 7.48M 331M |
| Net Debt | -876M -9.15M -8.02M -7.41M -6.85M -12.98M -13.24M -89.07M -34.61M -429M -34.36M -33.61M -1.49B | -1.13B -11.77M -10.32M -9.53M -8.81M -16.69M -17.03M -115M -44.51M -551M -44.19M -43.23M -1.91B |
Employees
453
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | ₹67.80 | -0.82% | 14,305 |
| 07/07/26 | ₹68.36 | -0.07% | 5,300 |
| 06/07/26 | ₹68.41 | -0.45% | 5,187 |
| 03/07/26 | ₹68.72 | -0.54% | 5,100 |
| 02/07/26 | ₹69.09 | +0.29% | 6,161 |
- Stock Market
- Stocks
- ALPA Stock
Select your edition
All financial news and data tailored to specific country editions
















